An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
Breast Cancer Res
; 23(1): 30, 2021 03 04.
Article
in En
| MEDLINE
| ID: mdl-33663560
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Triple Negative Breast Neoplasms
Type of study:
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Breast Cancer Res
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
United States